Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Cited In for PubMed (Select 16300471)

1.

LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.

Bentz GL, Moss CR 2nd, Whitehurst CB, Moody CA, Pagano JS.

J Virol. 2015 Aug 1;89(15):7465-77. doi: 10.1128/JVI.00711-15. Epub 2015 May 6.

PMID:
25948750
2.

Sumo E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes.

Gupta MK, Gulick J, Liu R, Wang X, Molkentin JD, Robbins J.

Circ Res. 2014 Sep 26;115(8):721-9. doi: 10.1161/CIRCRESAHA.115.304760. Epub 2014 Aug 5.

PMID:
25097219
3.

Sumoylation of human argonaute 2 at lysine-402 regulates its stability.

Sahin U, Lapaquette P, Andrieux A, Faure G, Dejean A.

PLoS One. 2014 Jul 18;9(7):e102957. doi: 10.1371/journal.pone.0102957. eCollection 2014.

4.

Identification of interconnected markers for T-cell acute lymphoblastic leukemia.

Maiorov EG, Keskin O, Ng OH, Ozbek U, Gursoy A.

Biomed Res Int. 2013;2013:210253. doi: 10.1155/2013/210253. Epub 2013 Jul 15.

5.

It takes two to tango: Ubiquitin and SUMO in the DNA damage response.

Bologna S, Ferrari S.

Front Genet. 2013 Jun 11;4:106. doi: 10.3389/fgene.2013.00106. eCollection 2013.

6.

Ubiquitin-conjugating enzyme 9 promotes epithelial ovarian cancer cell proliferation in vitro.

Dong M, Pang X, Xu Y, Wen F, Zhang Y.

Int J Mol Sci. 2013 May 24;14(6):11061-71. doi: 10.3390/ijms140611061.

7.

An electrophoretic mobility shift assay identifies a mechanistically unique inhibitor of protein sumoylation.

Kim YS, Nagy K, Keyser S, Schneekloth JS Jr.

Chem Biol. 2013 Apr 18;20(4):604-13. doi: 10.1016/j.chembiol.2013.04.001.

8.

Modification by ubiquitin-like proteins: significance in apoptosis and autophagy pathways.

Cajee UF, Hull R, Ntwasa M.

Int J Mol Sci. 2012;13(9):11804-31. doi: 10.3390/ijms130911804. Epub 2012 Sep 19.

9.

Gold nanoparticles as a platform for creating a multivalent poly-SUMO chain inhibitor that also augments ionizing radiation.

Li YJ, Perkins AL, Su Y, Ma Y, Colson L, Horne DA, Chen Y.

Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4092-7. doi: 10.1073/pnas.1109131109. Epub 2012 Mar 2.

10.

Human pathogens and the host cell SUMOylation system.

Wimmer P, Schreiner S, Dobner T.

J Virol. 2012 Jan;86(2):642-54. doi: 10.1128/JVI.06227-11. Epub 2011 Nov 9. Review.

11.

Ubc9 expression predicts chemoresistance in breast cancer.

Chen SF, Gong C, Luo M, Yao HR, Zeng YJ, Su FX.

Chin J Cancer. 2011 Sep;30(9):638-44. doi: 10.5732/cjc.011.10084.

12.

Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9.

Bentz GL, Whitehurst CB, Pagano JS.

J Virol. 2011 Oct;85(19):10144-53. doi: 10.1128/JVI.05035-11. Epub 2011 Jul 27.

13.

SUMOylation modulates the function of Aurora-B kinase.

Fernández-Miranda G, Pérez de Castro I, Carmena M, Aguirre-Portolés C, Ruchaud S, Fant X, Montoya G, Earnshaw WC, Malumbres M.

J Cell Sci. 2010 Aug 15;123(Pt 16):2823-33. doi: 10.1242/jcs.065565. Epub 2010 Jul 27.

14.

Identification and characterization of proteins that selectively interact with the LHR mRNA binding protein (LRBP) in rat ovaries.

Wang L, Gulappa T, Menon KM.

Biochim Biophys Acta. 2010 May;1803(5):591-7. doi: 10.1016/j.bbamcr.2010.02.003. Epub 2010 Feb 16.

15.

Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.

Zhu S, Sachdeva M, Wu F, Lu Z, Mo YY.

Oncogene. 2010 Mar 25;29(12):1763-72. doi: 10.1038/onc.2009.459. Epub 2009 Dec 21.

16.

Beyond CA125: the coming of age of ovarian cancer biomarkers. Are we there yet?

Sasaroli D, Coukos G, Scholler N.

Biomark Med. 2009 Jun 1;3(3):275-288.

17.

Chromatin-modifying enzymes as therapeutic targets--Part 2.

Keppler BR, Archer TK.

Expert Opin Ther Targets. 2008 Nov;12(11):1457-67. doi: 10.1517/14728222.12.11.1457 . Review.

18.

Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts.

Yates KE, Korbel GA, Shtutman M, Roninson IB, DiMaio D.

Aging Cell. 2008 Oct;7(5):609-21. doi: 10.1111/j.1474-9726.2008.00411.x. Epub 2008 Jul 24.

19.

Quantitative analysis of multi-protein interactions using FRET: application to the SUMO pathway.

Martin SF, Tatham MH, Hay RT, Samuel ID.

Protein Sci. 2008 Apr;17(4):777-84. doi: 10.1110/ps.073369608.

20.

Epigenetic regulation of protein-coding and microRNA genes by the Gfi1-interacting tumor suppressor PRDM5.

Duan Z, Person RE, Lee HH, Huang S, Donadieu J, Badolato R, Grimes HL, Papayannopoulou T, Horwitz MS.

Mol Cell Biol. 2007 Oct;27(19):6889-902. Epub 2007 Jul 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk